Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-22

FDA Approved: LACOSAMIDE — Original Application (Glenmark Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Glenmark's lacosamide generic drug under an Original Application (ANDA 215379). Lacosamide is indicated as adjunctive therapy for partial-onset sei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (generic) (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)